BED and EQD2 — Comparing Two Different Radiation Schedules

Not by the total Gray. Two schedules are put on a common scale using BED and EQD2 — arithmetic that accounts for the size of each fraction, not only the total. Once both are converted, a five-session course and a twenty-session course can finally be read side by side in the same units.

The number written on a radiation plan is a total, expressed in Gray (Gy), alongside a count of sessions. Those two numbers are not independent. Splitting a total into a few large pieces is biologically different from splitting the same total into many small ones. That is why a plan sheet showing a smaller total can represent an equal or greater effect than one showing a larger total.

Radiation oncologists resolve this with the linear-quadratic model, the framework behind BED and EQD2 and the standard approach in ASTRO-aligned practice. It converts any schedule into a single comparable figure. Nothing about it is exotic; it is the everyday currency conversion of radiation planning.

The catch, and the part most explanations skip, is that one schedule does not produce one number. It produces several. The converted value depends on which tissue you are asking about, because tumour tissue and late-responding healthy tissue react to fraction size differently. That is not a flaw in the method. It is the whole point of it.

Everything below is general education about how schedules are compared. It is not a recommendation, and it cannot tell you what is right for your own diagnosis — only your radiation oncologist can do that.

Usually not in the way it looks. A shorter course is a lower number of Gray on paper, but each session delivers a larger dose. Larger fractions carry more biological effect for every Gray delivered. Once that is accounted for, a fifteen-session course can sit close to a thirty-session one.

This is the single most common source of quiet panic on a radiation plan. A patient compares totals with someone else in the waiting area and concludes they are being short-changed. The comparison is not wrong to make. It is simply being made in the wrong units.

Delivering more dose in each sitting is called hypofractionation. It shortens the overall course. Guideline bodies including NCCN and ASTRO describe hypofractionated schedules as established options for selected cancer sites, and the choice between a long and a short course is made on the diagnosis, the site and the goal of treatment — not on convenience.

For families travelling in from a district, the practical difference is real. Fewer sittings means fewer journeys, fewer nights away from home and fewer days of work lost. Those are legitimate considerations for your team to weigh alongside the clinical ones, and worth raising openly rather than assuming they will be dismissed.

A shorter schedule is not automatically better or worse than a longer one. It is a different way of arriving at a comparable biological effect, chosen for reasons your radiation oncologist can explain to you directly.

Because Gray measures energy absorbed, not biological effect. The same total delivered in bigger pieces does more to tissue than the same total delivered in smaller pieces. BED and EQD2 restate both schedules in one currency, so two plans built on different fraction sizes can be compared honestly rather than by eye.

BED stands for biologically effective dose. It is a theoretical maximum on an open-ended scale, useful for ranking schedules but hard to read intuitively. EQD2 takes the same information and expresses it as a familiar figure: the dose in 2 Gy fractions that would have produced a comparable effect. Most conversations between a patient and a radiation oncologist happen in EQD2 for exactly that reason.

This is why the same schedule yields more than one converted number. Tumours and early-responding tissues such as skin and the lining of the gut are generally modelled with a higher α/β, commonly taken as around 10 Gy. Late-responding healthy tissues such as nerve, lung and connective tissue are modelled with a lower value, commonly around 3 Gy. A low value means large fractions hit that tissue harder.

Certain sites are recognised exceptions where the tumour itself behaves more like a late-responding tissue. That biology is one of the reasons short, large-fraction schedules became established for some cancers and not for others. It is also why a schedule that suits one diagnosis cannot simply be lifted across to another.

Radiotherapy is delivered at an NABH-accredited partner centre; CION Cancer Clinics coordinates your treatment plan, your oncology team and your care throughout, including the review appointment where questions like this get answered properly.

Read the first column and schedule C looks like the smallest course on the table. Read the converted columns and it is by some distance the largest. Halving the number of Gray on paper while raising the fraction size fivefold does not halve anything biologically. This single row is the answer to “my friend got 33 and I got 15 — am I getting less?”

Notice too that schedule A gives the same figure in both EQD2 columns. That is not a coincidence. A schedule already delivered in 2 Gy fractions converts to itself, whatever α/β value you choose. It is the reference point the whole scale is anchored to.

What the conversion cannot tell you

The last column of schedule C looks alarming, and read in isolation it would be. It is not the whole story. Schedules built on a few large fractions are used with techniques that treat a much smaller volume and let the dose fall away very steeply at the edges, so the amount of healthy tissue actually receiving that dose is small. Volume matters as much as dose, and no formula on this page contains volume.

There is a second caveat worth knowing. The linear-quadratic model is least reliable at very large fraction sizes, a limitation openly discussed in ASTRO-aligned radiobiology literature, and specialist teams apply modified approaches in that range. It also says nothing about how long the overall course runs, which matters in its own right for some cancer sites.

Which is why the arithmetic is a tool for a conversation, not a verdict. A converted number tells you how two schedules relate on one axis. Your radiation oncologist and the tumour board weigh several more before a plan is approved.

• Want to know what set the total on your plan in the first place, before any conversion? What Decides the Total Radiation Dose You Receive walks through the four inputs behind the prescription.
• Seen the coloured bands on your plan image and wondered what they show? Isodose Lines and Colour Washes: Reading a Radiation Plan Image explains how dose is displayed and why the edges fall away.
• Curious why the graph of dose against volume comes up in every planning discussion? What Is a DVH (Dose Volume Histogram)? covers the volume side that BED and EQD2 leave out.
• Been told your tumour may respond less predictably to radiation? Tumour Hypoxia: Why Oxygen Matters in Radiation Treatment explains one of the biological reasons behind that.
• For the full picture of how radiation is planned, delivered and coordinated with NABH-accredited partner centres, see Radiation Therapy at CION Cancer Clinics.

Still holding two plan sheets and no way to compare them? Book a free consultation and a radiation oncologist will do it with you properly, or call 1800 202 8726.